• American Chamber of Commerce in Korea
  • Your Partner in Business Since 1953


home> >

AMCHAM Legal Affairs Committee Meeting

Thursday, December 08, 2022

7:30 AM - 9:30 AM


Andaz Seoul Gangnam Hotel, Studio III (B2)

IP Litigation in the U.S. can be quite challenging. The Safe Harbor Defense under 35 U.S.C. §271(e)(1) immunizes certain “acts” from patent infringement when performed “solely for uses reasonably related to the development and submission of information” to FDA. But the courts have interpreted the statute inconsistently, creating ambiguity as to whether an otherwise infringing activity is exempt. Our speaker will review several historical Safe Harbor cases, as well as recent decisions, to clarify the scope of the defense. Please join us for an informative session by a pre-eminent practitioner and bring any questions you may have on this and related topics!


TOPIC Navigating the Safe Harbor Defense to U.S. Patent Infringement under 35 USC 271(e)(1)
COST KRW 77,000 for members
KRW 77,000 for non-members (My company is an AMCHAM member)
KRW 99,000 for non-members
Noon, Tuesday, December 06, 2022

* No refunds or cancellations after this date and time.
* 2 complimentary admission for Founding Partners.

About the Speaker

Kristel Schorr, Partner and Intellectual Property Lawyer, Foley & Lardner LLP

Kristel Schorr is a partner and intellectual property lawyer with Foley & Lardner LLP. She is chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and a member of the firm’s Partner Selection Committee. Kristel counsels life science clients regarding all aspects of intellectual property, including due diligence analyses, invalidity, non-infringement and freedom to operate opinions, IP portfolio management, patent prosecution, post-grant and interference proceedings. Her legal practice spans a number of technical areas, including immunology, molecular and cell biology, protein chemistry, oligonucleotide therapeutics, oncology, small molecule pharmaceutical compositions and drug delivery systems, but her work often involves cell based therapeutics, and biologics such as antibodies and other large molecule receptor agonists and antagonists. Kristel graduated from The George Washington University Law School (J.D., 2004), received her doctorate in medical physiology from the University of Maryland School of Medicine (Ph.D., 2000) and her undergraduate degree from The Pennsylvania State University (B.S., 1994).


(email) amchamrsvp@amchamkorea.org

(phone) 02-6201-2255